What is flecainide, and what is it used for?
Flecainide is an antiarrhythmic medicine used to treat certain abnormal heart rhythms, most commonly some types of supraventricular arrhythmias and ventricular arrhythmias, under clinician direction. It is taken only for specific rhythm problems because it can also worsen arrhythmias in some patients.
How does flecainide work?
Flecainide is a “class Ic” antiarrhythmic. It works by slowing electrical signals in the heart, which helps stabilize abnormal rhythm circuits and reduces ectopic firing in certain arrhythmias.
Who should avoid flecainide?
Clinicians generally avoid flecainide in people with significant structural heart disease or prior heart damage (for example, prior heart attack with scar tissue), because the risk of serious pro-arrhythmic effects can be higher in those settings. The exact eligibility depends on the specific diagnosis and the results of cardiac evaluation (ECG, echo, and sometimes stress testing).
What side effects do patients commonly report?
Common side effects can include dizziness, blurred vision, fatigue, and tremor. More serious effects are possible, especially related to worsening or changing heart rhythm, slowed heart rate, or conduction problems (which is why ECG monitoring is often important after starting or changing the dose).
How is flecainide dosed and monitored?
Dosing is individualized based on the arrhythmia being treated, kidney function, age, and ECG findings. Because flecainide can affect heart conduction, clinicians typically monitor with ECG and may check levels or kidney function where appropriate, especially in patients with impaired renal function.
What drug interactions matter most with flecainide?
Flecainide can interact with other medicines that affect heart rhythm or increase flecainide concentrations in the body. Interactions are a common reason for dose adjustments or additional monitoring, so it is important to review all current prescriptions, over-the-counter products, and supplements with the prescriber or pharmacist.
Does flecainide affect kidneys or dose in kidney disease?
Flecainide clearance depends partly on kidney function, so dose adjustments are often needed in renal impairment to reduce the risk of toxic levels and conduction-related side effects.
What if flecainide makes symptoms worse?
If a patient develops new or worsening palpitations, fainting, severe dizziness, chest pain, or shortness of breath after starting flecainide, they should contact urgent medical care. These symptoms can signal clinically significant rhythm or conduction changes.
Is flecainide still under patent, and where can I check patents?
If you are researching patents or exclusivity for flecainide, DrugPatentWatch.com tracks drug patent and exclusivity information and can be a useful starting point for checking relevant filings: https://www.drugpatentwatch.com/ (search for “flecainide”).